Turning Point Brands, Inc. (TPB) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's earnings call highlights an increase in EBITDA guidance and nicotine pouch sales, indicating strong financial performance. The Q&A section reveals confidence in capacity expansion and strategic growth in Modern Oral products. Despite some margin pressures and negative free cash flow, the company's positive guidance and strategic investments in growth areas suggest a likely positive stock price reaction.
Key Financial Performance
Revenue Revenue increased 31% to $119 million for the quarter, including $36.7 million net Modern Oral revenue, which includes $1.5 million of slotting fees that are accounted for as contra revenue.
Adjusted EBITDA Adjusted EBITDA increased 17% to $31.3 million for the quarter.
White nicotine pouch sales White pouch sales increased 628% year-over-year and 22% sequentially. The growth is attributed to their long-lasting vibrant flavor options, comfortable mouth feel, and flexible nicotine levels resonating with consumers.
Stoker's revenue Stoker's revenue increased 81% to about $74.8 million, reflecting a 4% increase in looseleaf, a 6% increase in MST, and the aforementioned 628% increase in Modern Oral revenue.
Zig-Zag revenue Zig-Zag revenue was down 11% to $44.2 million and down 6% sequentially. The decline reflects some opportunity costs related to the focus on Modern Oral.
Gross margin Gross margin was 59.2%, which was up 360 basis points year-over-year and 210 basis points sequentially. The change in margin is mix driven, primarily related to outsized growth in Modern Oral.
SG&A expenses Reported SG&A was $44.5 million for the quarter, which was up $4.2 million sequentially. This increase was primarily driven by Modern Oral related sales and marketing investments as well as increased outbound freight charges to support the growing business.
Free cash flow Free cash flow for the third quarter was negative $1 million, including the first coupon payment on the 7.625% high-yield bond issued in February of 2025.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
White nicotine pouch brands: Sales increased 628% year-over-year and 22% sequentially. ALP, initially expected to be exclusive D2C for 2025, started appearing on bricks-and-mortar shelves ahead of schedule.
FRE Watermelon: Launched as a new flavor in the nicotine pouch category, positioned as a first mover with a complete strength offering.
Stoker's Fine Cut Wintergreen cans: New product launched in the Stoker's segment.
Zig-Zag Natural Leaf Flat Wraps: Laid groundwork for launch to compete in the Natural Leaf segment.
International expansion: Investments in expanding to international markets for Modern Oral business.
Retail expansion: ALP nicotine pouches started appearing in select retailer tests ahead of schedule.
Sales force expansion: Ahead of schedule in doubling the size of the sales force by the end of 2026.
Manufacturing improvements: Building U.S. manufacturing to improve white pouch profitability and mitigate supply chain and tariff risks. First production lines expected in the first half of 2026.
Marketing investments: Increased investments in sales and marketing for Modern Oral products, including partnerships and collaborations.
Capital deployment: Raised $100 million in gross proceeds to accelerate Modern Oral business growth. Updated ATM prospectus and buyback authorization to $200 million each.
Focus on Modern Oral: Prioritizing FRE and ALP nicotine pouches while maintaining cash flow from heritage brands.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Supply Chain and Tariff Risks: The company is investing in U.S. manufacturing to mitigate supply chain and tariff risks, indicating potential challenges in sourcing and cost management.
Zig-Zag Revenue Decline: Zig-Zag sales decreased 11% year-over-year, reflecting opportunity costs related to the focus on Modern Oral products.
Increased SG&A Expenses: SG&A expenses rose by $4.2 million sequentially, driven by sales and marketing investments and increased outbound freight charges, which could pressure margins.
Negative Free Cash Flow: The company reported negative free cash flow of $1 million for the quarter, partly due to high-yield bond coupon payments, which could impact liquidity.
Regulatory and Tariff Impacts: Guidance reflects tariff and currency-related impacts, suggesting exposure to regulatory and international trade risks.
Competitive Pressures in Nicotine Pouch Market: The company anticipates a competitive market with five to six dominant brands, requiring significant investments to secure market share.
Focus on Modern Oral Products: The focus on Modern Oral products may lead to opportunity costs and resource allocation challenges for legacy brands like Zig-Zag.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Adjusted EBITDA Guidance: Increased to a range of $115 million to $120 million, up from $110 million to $114 million for the full year 2025.
Nicotine Pouch Sales Guidance: Full year consolidated nicotine pouch sales guidance increased to a range of $125 million to $130 million, up from $100 million to $110 million.
Market Opportunity in Nicotine Pouch Space: The nicotine pouch market is expected to approach or exceed $10 billion in manufacturers' revenue by the end of the decade. The company aims for a double-digit market share in this category.
Capital Deployment: Raised $100 million in gross proceeds to be deployed across high-return opportunities to accelerate Modern Oral business growth. Plans to update ATM prospectus supplement and buyback authorization to provide $200 million of capacity under each program.
Sales Force Expansion: Ahead of schedule in doubling the size of the sales force by the end of 2026.
Manufacturing Expansion: Plans to qualify the first production lines for U.S. manufacturing of white pouches in the first half of 2026 to improve profitability and mitigate supply chain and tariff risks.
New Product Launches: Launched FRE Watermelon flavor and plans to expand SKU offerings. Also laid groundwork for Zig-Zag Natural Leaf Flat Wraps.
Marketing and Brand Awareness: Investing in strategic marketing campaigns, including partnerships like Professional Bull Riders, to accelerate brand awareness and consumer loyalty.
CapEx for Modern Oral Business: Expected to spend $3 million to $5 million for the full year 2025 to supplement Modern Oral PMTAs.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Buyback Authorization: The company plans to update its ATM prospectus supplement and buyback authorization to provide for $200 million of capacity under each program. However, there are no current plans to transact under the updated authorizations.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:How should we think about onshoring from a capacity standpoint and its impact on COGS per unit for nicotine pouches?
A:Onshoring will lead to immediate savings in inbound freight and tariff avoidance once the lines are qualified, expected in the first half of 2026. Over time, as volume increases, unit economics are expected to improve further.
Q:What is the capacity outlook for nicotine pouches?
A:The company feels confident about the capacity with their third-party manufacturer, and the U.S. capacity will be additive, ensuring a strong position both in inventory and future capacity.
Q:What are the early in-store market share results for the Modern Oral category?
A:The company has not disclosed specific market share data but is encouraged by the results, focusing on in-store selling and distribution growth.
Q:What is driving growth in MST and looseleaf categories?
A:Growth is driven by a combination of sequential market share gains and favorable pricing. The category is expected to sell over 900 million cans, with the company holding a high single-digit share, indicating significant growth potential.
Q:What are the drivers for Modern Oral growth, and what is the expected cadence for larger chain expansions?
A:Both FRE and ALP showed healthy growth, with ALP dominating in B2C and making inroads into brick-and-mortar. FRE performed well online and in stores. The company is progressing in expanding SKU assortments and engaging in planogram discussions with major chains for future quarters.
Q:How did the company handle promotions in the Modern Oral category, and what is their view on the competitive landscape?
A:The company maintained pricing integrity during a promotional-heavy Q3, focusing on shelf space and in-store presence. They plan to take a measured approach to promotional investments, leveraging consumer data and online platforms to guide decisions.
Q:What are the white space opportunities for FRE and ALP in distribution, and how do they plan to promote the brands together?
A:There is significant white space for both brands, especially ALP, which has focused on D2C. The company is investing in sales infrastructure and exploring shared platforms in stores to maximize distribution and consumer reach.
Q:How does the company balance profitability and growth, and what is the outlook for EBITDA margins?
A:The company aims to balance growth and profitability, deploying resources on high-return projects. While maintaining a healthy EBITDA margin of 26% YTD, there may be some margin pressure due to investments in promotional activities.
Q:What is the outlook for shelf space allocation for Modern Oral products?
A:Retailers are methodically allocating shelf space, with an expected increase for Modern Oral products due to category growth. Specific products to be displaced are unclear due to regional preferences.
Q:How are the ALP and FRE loyalty programs performing, and what is their impact on consumer engagement?
A:The loyalty programs are growing and engaging valuable repeat customers. Subscription sign-ups for both brands are encouraging, indicating strong consumer adoption.
Q:Why does the updated guidance for Modern Oral imply slower sequential revenue growth?
A:The slower growth is attributed to contra revenue from shelf placement negotiations. The company plans to provide more details on gross versus net sales in future quarters.
Q:What is driving the strong gross margin in the Stoker's segment?
A:Higher margins are driven by a mix shift towards D2C in Modern Oral. Freight expenses in SG&A and tariffs are expected to compress margins slightly in the short term.
Q:What is the outlook for the promotional environment in the Modern Oral category?
A:The promotional environment is expected to remain competitive due to well-financed competitors. The company focuses on building brand connections and selectively investing in consumer acquisition.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on early in-store market share for the Modern Oral category, differentiation between FRE and ALP performance, and which products might lose shelf space due to Modern Oral's growth. Additionally, they did not disclose specifics on their investment strategy for balancing profitability and growth or the exact impact of promotions on future margins.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ALP DC
ALP pouch
ATM
Chief
FRE ALP
Louisville
Modern Oral
Natural Leaf
Officer
Summer
UPS
Watermelon
Zig Zag
Zig product
authorization
campaign
capital
collaboration
community
effort
family
heritage
investment market
legacy
nicotine pouch
pouch brand
pouch sale
premium
price
proceeds
program
return
sale FRE
sale force
schedule
shelf
supply
tariff
town
tragedy
yesterday
TPB Transcript
Turning Point Brands, Inc. (TPB) Q1 2026 Earnings Call Transcript
Positive5-7
The earnings call shows strong sales growth, particularly in the Modern Oral segment, with gross and net sales up significantly year-over-year and sequentially. Despite some market expansion challenges and execution risks, the overall financial performance is robust. The lack of negative sentiment in the Q&A and no mention of shareholder returns do not detract from the positive outlook. Given these factors, the stock price is likely to experience a positive movement in the short term.
Turning Point Brands, Inc. (TPB) Q4 2025 Earnings Call Transcript
Positive3-2
The earnings call revealed strong financial performance with a 29% revenue increase and a 14% rise in adjusted EBITDA. The company is expanding its sales force and manufacturing capabilities, indicating growth potential. Despite some declines in Zig-Zag segment sales, the focus on Modern Oral products shows strategic prioritization. Positive guidance on nicotine pouch sales and adjusted EBITDA, alongside a $100 million capital raise, suggests confidence in future growth. The Q&A section highlighted strategic investments and market opportunities, with management addressing potential risks effectively. Overall, the sentiment is positive, anticipating a stock price increase.
Air Canada (AC:CA) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call indicates positive sentiment with increased guidance for EBITDA and nicotine pouch sales. The Q&A section confirms a favorable revenue environment and strategic growth plans, such as sales force expansion and market share targets. Although there are some concerns, like headwinds in the Zig-Zag segment, the overall outlook remains optimistic with strong modern oral sales projections and strategic investments. The increased guidance and strategic initiatives suggest a likely positive stock price movement.
Turning Point Brands, Inc. (TPB) Q3 2025 Earnings Call Transcript
Positive11-5
The company's earnings call highlights an increase in EBITDA guidance and nicotine pouch sales, indicating strong financial performance. The Q&A section reveals confidence in capacity expansion and strategic growth in Modern Oral products. Despite some margin pressures and negative free cash flow, the company's positive guidance and strategic investments in growth areas suggest a likely positive stock price reaction.
TPB Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
